PURDUE PHARMACEUTICAL PRODUCTS, L.P. et al > Documents
Date Field | Doc. No. | Description (Pages) |
---|---|---|
Aug 30, 2012 | 6 | SMS-3 (2) |
Aug 30, 2012 | 6 | SMS-3 (2) |
Aug 30, 2012 | 4 | Corporate Disclosure Statement (2) |
Aug 30, 2012 | 3 | Corporate Disclosure Statement (2) |
Aug 30, 2012 | 1 | Main Document (13) |
Aug 30, 2012 | 1 | Main Document (13) |
Aug 30, 2012 | 1 | Main Document (13) |
Aug 30, 2012 | 5 | Corporate Disclosure Statement (2) |
Aug 30, 2012 | 1 | EXH A (27) |
Aug 30, 2012 | 1 | EXH A (27) |
Aug 30, 2012 | 1 | EXH A (27) |
Aug 30, 2012 | 2 | EXH B (39) |
Aug 30, 2012 | 2 | EXH B (39) |
Aug 30, 2012 | 2 | EXH B (39) |
Aug 30, 2012 | 3 | CIV COV (2) |
Aug 30, 2012 | 3 | CIV COV (2) |
Aug 30, 2012 | 3 | CIV COV (2) |
Aug 30, 2012 | 4 | SMS-1 (2) |
Aug 30, 2012 | 5 | SMS-2 (1) |
Aug 30, 2012 | 4 | SMS-1 (2) |
Aug 30, 2012 | 4 | SMS-1 (2) |
Aug 30, 2012 | 6 | SMS-3 (2) |
Aug 30, 2012 | 5 | SMS-2 (1) |
Aug 30, 2012 | 5 | SMS-2 (1) |